Complex I deficiency related to T10158C mutation ND3 gene: A further definition of the clinical spectrum

Abstract Background Complex I deficiency is the most common energy generation disorder which may clinically present at any age with a wide spectrum of symptoms and signs. The T10158C mutation ND3 gene is rare and occurs in patients showing an early rapid neurological deterioration invariably leading...

Full description

Saved in:
Bibliographic Details
Published inBrain & development (Tokyo. 1979) Vol. 39; no. 3; pp. 261 - 265
Main Authors Grosso, Salvatore, Carluccio, Maria Alessandra, Cardaioli, Elena, Cerase, Alfonso, Malandrini, Alessandro, Romano, Chiara, Federico, Antonio, Dotti, Maria Teresa
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.03.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Complex I deficiency is the most common energy generation disorder which may clinically present at any age with a wide spectrum of symptoms and signs. The T10158C mutation ND3 gene is rare and occurs in patients showing an early rapid neurological deterioration invariably leading to death after a few months. Case presentation We report a 9 year-old boy with a mtDNA T10158C mutation showing a mild MELAS-like phenotype and brain MRI features congruent with both MELAS and Leigh syndrome. Epilepsia partialis continua also occurred in the clinical course and related to a mild cortical atrophy of the left perisylvian area. Discussion The present case confirms that the clinical spectrum of Complex I deficiency related to T10158C mutation ND3 gene is wider than previously described. Our observation further suggests that testing mutation in the MT-ND3 gene should be included in the diagnostic work-up of patients presenting with epilepsia partialis continua accompanied by suspicion of mitochondrial disorder.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0387-7604
1872-7131
DOI:10.1016/j.braindev.2016.09.013